Global Non-Invasive Prenatal Testing and Newborn Screening Market 2017-2027 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2027" report to their offering.

The "Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2027" report features an extensive study on the current market landscape of non-invasive prenatal testing (NIPT) and newborn screening diagnostics that are commercially available or are under development.

NIPT and newborn screening tests are designed for the detection of different types of genetic abnormalities in fetuses and newborns. Detection of genetic disorders in prenatal and neonatal stages is critical tolower the child mortality rates. Moreover, early detection, treatment and management of these genetic disorders is important to avoid serious health problems at later stages in life. The study offers a comprehensive discussion on the future potential of these tests in prenatal and neonatal care.

Ever since the launch and subsequent success of the first NIPT, the NIFTY® test (launched by BGI in August 2011), several firms have taken initiatives to develop and commercialize NIPTs. Currently, a number of NIPTs that are designed to screen for conditions such as chromosomal abnormalities, sex chromosomal abnormalities and microdeletion syndromes are available in the market.

In addition, many companies have entered into collaborations to distribute these tests across various geographies in order to expand the availability to a wider population. Examples of popular NIPT tests include Harmony® test (Ariosa Diagnostics, acquired by Roche), PraenaTest®/PrenaTest® (LifeCodexx, a subsidiary of GATC Biotech), Panorama® (Natera®), NIFTY® (BGI), Verifi® (Verinata Health, acquired by Illumina®), VisibiliTTM (SequenomTM, acquired by LabCorp®) and IONA® test/Safe NIPT (Premaitha Health).

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. NIPT And Newborn Screening: Market Landscape

5. NIPT And Newborn Screening: Key Insights

6. Prenatal Testing: Focus On NIPT

7. Newborn Screening: Detailed Outlook

8. Other Associated Tests And Services

9. Recent Collaborations

10. NIPT And Newborn Screening: Market Sizing And Forecast

11. Conclusion

12. Interview Transcripts

13. Survey Analysis

14. Appendix 1: Tabulated Data

15. Appendix 2: List Of Companies And Organizations

For more information about this report visit https://www.researchandmarkets.com/research/7qqjvl/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Women's Health, Maternal and Neonatal Care

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Women's Health, Maternal and Neonatal Care